Preadipocyte to adipocyte: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 15: | Line 15: | ||
|TCSample_description=We are using two different models of human adipogenesis in the FANTOM5 study. Both originate from the stromal-vascular fraction (SVF) of human subcutaneous adipose tissue. | |TCSample_description=We are using two different models of human adipogenesis in the FANTOM5 study. Both originate from the stromal-vascular fraction (SVF) of human subcutaneous adipose tissue. | ||
The first model, here called preadipocytes, consists of cells differentiated in vitro directly after SVF isolation from adipose tissue. This means only later stages of differentiation can be monitored as samples in the beginning contain other cell types, like immune and endothelial cells, that contaminates the results. These contaminants die off after approximately 3-4 days. For this model we have taken tissue from four donors and sampled differentiation at time-points 4, 8 and 12 days after differentiation start. We have also isolated mature adipocytes from the adipose tissue of these donors. | The first model, here called preadipocytes, consists of cells differentiated in vitro directly after SVF isolation from adipose tissue. This means only later stages of differentiation can be monitored as samples in the beginning contain other cell types, like immune and endothelial cells, that contaminates the results. These contaminants die off after approximately 3-4 days. For this model we have taken tissue from four donors and sampled differentiation at time-points 4, 8 and 12 days after differentiation start. We have also isolated mature adipocytes from the adipose tissue of these donors. | ||
For the other model system, here called human adipose-derived mesenchymal stem cells (hASC), we have propagated cells from the SVF in vitro thus selecting for a stem cell/progenitor population. These cells can be expanded and cultured for several passages. This gives us cells with a homogenous genetic background and since contaminants are removed from the beginning, differentiation can be monitored from start to finish. Here we have collected triplicate samples at 0, 15, 30, 45 min, 1 h, 1 h 20 min, 1 h 40 min, 2 h, 2 h 30 min, 3 h, 12 h and 1, 2, 4, 8, 12 and 14 days after differentiation start. | For the other model system, here called human adipose-derived mesenchymal stem cells (hASC), we have propagated cells from the SVF in vitro thus selecting for a stem cell/progenitor population. These cells can be expanded and cultured for several passages. This gives us cells with a homogenous genetic background and since contaminants are removed from the beginning, differentiation can be monitored from start to finish. Here we have collected triplicate samples at 0, 15, 30, 45 min, 1 h, 1 h 20 min, 1 h 40 min, 2 h, 2 h 30 min, 3 h, 12 h and 1, 2, 4, 8, 12 and 14 days after differentiation start. <br> | ||
<br> | |||
<html><img src='https://fantom5-collaboration.gsc.riken.jp/resource_browser/images/TC_qc/500px-HAdipogenesis_timeline.png' /></html><br> | |||
<br> | |||
''Figure 1. Sample collection scheme for the different model system. Sample collection time points are indicated as well as the removal of some components of the differentiation cocktail. IBMX=3-isobutyl-1-methylxanthine, Dexam.=dexamethasone, Rosig.=Rosiglitazone.'' | |||
|TCQuality_control= | |TCQuality_control= | ||
}} | }} |
Revision as of 13:24, 9 December 2014
Series: | IN_VITRO DIFFERENTIATION SERIES |
---|---|
Species: | Human (Homo sapiens) |
Genomic View: | Zenbu |
Expression table: | [{{{tet_config}}} FILE] |
Link to TET: | [{{{tet_file}}} TET] |
Sample providers : | Peter Arner |
Germ layer: | {{{germ_layer}}} |
Primary cells or cell line: | {{{primary_cells}}} |
Time span: | {{{time_span}}} |
Number of time points: | {{{number_time_points}}} |
Overview |
---|
Adipose tissue can account for between 5% (lean athletes) and 60% (morbidly obese) of total body mass, making it one of the most plastic organs in the body [8]. In response to changed nutritional status, both adipocyte cell number and size change and even under stable conditions as much as 10% of the adipocytes are turned over annually [1,2]. Thus the birth of new adipocytes from precursor cells (adipogenesis) is central for a functional fat tissue. |
Sample description |
---|
We are using two different models of human adipogenesis in the FANTOM5 study. Both originate from the stromal-vascular fraction (SVF) of human subcutaneous adipose tissue.
The first model, here called preadipocytes, consists of cells differentiated in vitro directly after SVF isolation from adipose tissue. This means only later stages of differentiation can be monitored as samples in the beginning contain other cell types, like immune and endothelial cells, that contaminates the results. These contaminants die off after approximately 3-4 days. For this model we have taken tissue from four donors and sampled differentiation at time-points 4, 8 and 12 days after differentiation start. We have also isolated mature adipocytes from the adipose tissue of these donors.
For the other model system, here called human adipose-derived mesenchymal stem cells (hASC), we have propagated cells from the SVF in vitro thus selecting for a stem cell/progenitor population. These cells can be expanded and cultured for several passages. This gives us cells with a homogenous genetic background and since contaminants are removed from the beginning, differentiation can be monitored from start to finish. Here we have collected triplicate samples at 0, 15, 30, 45 min, 1 h, 1 h 20 min, 1 h 40 min, 2 h, 2 h 30 min, 3 h, 12 h and 1, 2, 4, 8, 12 and 14 days after differentiation start. |
Quality control |
---|
Profiled time course samples
Only samples that passed quality controls (Arner et al. 2015) are shown here. The entire set of samples are downloadable from FANTOM5 human / mouse samples
13019-139D4 | Adipocyte differentiation | day04 | donor1 |
13020-139D5 | Adipocyte differentiation | day08 | donor1 |
13021-139D6 | Adipocyte differentiation | day12 | donor1 |
13022-139D7 | Adipocyte differentiation | day04 | donor2 |
13023-139D8 | Adipocyte differentiation | day08 | donor2 |
13024-139D9 | Adipocyte differentiation | day12 | donor2 |
13025-139E1 | Adipocyte differentiation | day04 | donor3 |
13026-139E2 | Adipocyte differentiation | day08 | donor3 |
13027-139E3 | Adipocyte differentiation | day12 | donor3 |
13028-139E4 | Adipocyte differentiation | day04 | donor4 |
13029-139E5 | Adipocyte differentiation | day08 | donor4 |
13030-139E6 | Adipocyte differentiation | day12 | donor4 |